BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother Res 2008;22:1125-32. [DOI: 10.1002/ptr.2472] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2120541] [Reference Citation Analysis]
2 Islam MR, Islam F, Nafady MH, Akter M, Mitra S, Das R, Urmee H, Shohag S, Akter A, Chidambaram K, Alhumaydhi FA, Emran TB, Cavalu S. Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint. Molecules 2022;27:2165. [PMID: 35408561 DOI: 10.3390/molecules27072165] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
3 Zhao M, Zheng YH, Zhao QY, Zheng W, Yang JH, Pei HY, Liu L, Liu KJ, Xue LL, Deng DX, Wang L, Ma X, Fu SH, Peng AH, Tang MH, Luo YZ, Ye HY, Chen LJ. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy. Eur J Med Chem 2021;209:112922. [PMID: 33069436 DOI: 10.1016/j.ejmech.2020.112922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Khatoon E, Banik K, Harsha C, Sailo BL, Thakur KK, Khwairakpam AD, Vikkurthi R, Devi TB, Gupta SC, Kunnumakkara AB. Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.06.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 17.5] [Reference Citation Analysis]
5 Noel B, Singh SK, Lillard JW Jr, Singh R. Role of natural compounds in preventing and treating breast cancer. Front Biosci (Schol Ed) 2020;12:137-60. [PMID: 32114452 DOI: 10.2741/S544] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
6 Zhuang Q, Pan R, Liu X, Xu W, Wang H, Zhang X, Lai X, Wang H, Zhang L, Jiang J. A validated ultra-HPLC-MS/MS method for determination of honokiol in human plasma and its application to a clinical pharmacokinetic study. Bioanalysis 2019;11:1085-98. [PMID: 31251102 DOI: 10.4155/bio-2019-0030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Muniraj N, Siddharth S, Sharma D. Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer. Cancers (Basel) 2019;11:E1563. [PMID: 31618928 DOI: 10.3390/cancers11101563] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
8 Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019;144:192-209. [DOI: 10.1016/j.phrs.2019.04.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 31.0] [Reference Citation Analysis]
9 Rauf A, Patel S, Imran M, Maalik A, Arshad MU, Saeed F, Mabkhot YN, Al-showiman SS, Ahmad N, Elsharkawy E. Honokiol: An anticancer lignan. Biomedicine & Pharmacotherapy 2018;107:555-62. [DOI: 10.1016/j.biopha.2018.08.054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
10 Tang H, Zhang Y, Li D, Fu S, Tang M, Wan L, Chen K, Liu Z, Xue L, Peng A, Ye H, Chen L. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer. Eur J Med Chem 2018;156:190-205. [PMID: 30006164 DOI: 10.1016/j.ejmech.2018.06.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
11 Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, Zhao C, Chai L, Chen X, Shao X, Wang C, Wu W, Wan L, Ye H, Qiu Q, Peng A, Wei Y, Yang L, Chen L. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget 2017;8:915-32. [PMID: 27906672 DOI: 10.18632/oncotarget.13687] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
12 Guillermo-Lagae R, Santha S, Thomas M, Zoelle E, Stevens J, Kaushik RS, Dwivedi C. Antineoplastic Effects of Honokiol on Melanoma. Biomed Res Int 2017;2017:5496398. [PMID: 28194418 DOI: 10.1155/2017/5496398] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
13 Shen R, Li J, Ye D, Wang Q, Fei J. Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma. Acta Biochim Biophys Sin (Shanghai) 2016;48:894-901. [PMID: 27590062 DOI: 10.1093/abbs/gmw082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
14 Pan J, Lee Y, Wang Y, You M. Honokiol targets mitochondria to halt cancer progression and metastasis. Mol Nutr Food Res 2016;60:1383-95. [DOI: 10.1002/mnfr.201501007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
15 Xie L, Jiang F, Zhang X, Alitongbieke G, Shi X, Meng M, Xu Y, Ren A, Wang J, Cai L, Zhou Y, Xu Y, Su Y, Liu J, Zeng Z, Wang G, Zhou H, Chen QC, Zhang XK. Honokiol sensitizes breast cancer cells to TNF-α induction of apoptosis by inhibiting Nur77 expression. Br J Pharmacol 2016;173:344-56. [PMID: 26505879 DOI: 10.1111/bph.13375] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
16 Zuo GY, Zhang XJ, Han J, Li YQ, Wang GC. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). BMC Complement Altern Med 2015;15:425. [PMID: 26627468 DOI: 10.1186/s12906-015-0938-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
17 Zhou M, Li Z, Han Z, Tian N. Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κB and Lin28 in Hep3B cells. J Recept Signal Transduct Res 2015;35:618-25. [PMID: 26108226 DOI: 10.3109/10799893.2015.1041644] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
18 Oh T, Ivan ME, Sun MZ, Safaee M, Fakurnejad S, Clark AJ, Sayegh ET, Bloch O, Parsa AT. PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma. Immunotherapy 2014;6:737-53. [PMID: 25186604 DOI: 10.2217/imt.14.35] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
19 He N, Zhang Z. Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway. Mol Cell Biochem 2015;405:187-96. [PMID: 25893737 DOI: 10.1007/s11010-015-2410-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog 2015;54:1710-21. [PMID: 25491779 DOI: 10.1002/mc.22242] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
21 Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. Am J Surg 2014;208:995-1002; discussion 1001-2. [PMID: 25450590 DOI: 10.1016/j.amjsurg.2014.09.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
22 Li Z, Wu C, Wu J, Ji M, Shi L, Jiang J, Xu B, Yuan J. Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells. Oncol Lett 2014;8:1603-7. [PMID: 25202376 DOI: 10.3892/ol.2014.2368] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
23 Maru G, Kumar G, Ghantasala S, Tajpara P. Polyphenol-Mediated In Vivo Cellular Responses during Carcinogenesis. Polyphenols in Human Health and Disease 2014. [DOI: 10.1016/b978-0-12-398456-2.00088-8] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kumar A, Kumar Singh U, Chaudhary A. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med Chem 2013;5:809-29. [PMID: 23651094 DOI: 10.4155/fmc.13.32] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
25 Lai H, Tang M, Liu J, Dong Y, Qiu N, Li S, Ma L, Yang J, Song H, Zhang Y, Peng A, Chen L. Identification of honokiol metabolites in rats by the method of stable isotope cluster technique and ultra-high performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. Journal of Chromatography B 2013;931:157-63. [DOI: 10.1016/j.jchromb.2013.05.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
26 Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J Cell Physiol 2012;227:2184-95. [PMID: 21792937 DOI: 10.1002/jcp.22954] [Cited by in Crossref: 120] [Cited by in F6Publishing: 124] [Article Influence: 12.0] [Reference Citation Analysis]
27 Shukla Y, George J. Combinatorial strategies employing nutraceuticals for cancer development. Ann N Y Acad Sci 2011;1229:162-75. [PMID: 21793852 DOI: 10.1111/j.1749-6632.2011.06104.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
28 Wang XH, Cai LL, Zhang XY, Deng LY, Zheng H, Deng CY, Wen JL, Zhao X, Wei YQ, Chen LJ. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol. Int J Pharm 2011;410:169-74. [PMID: 21397675 DOI: 10.1016/j.ijpharm.2011.03.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
29 Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. 2011;130:157-176. [PMID: 21277893 DOI: 10.1016/j.pharmthera.2011.01.010] [Cited by in Crossref: 287] [Cited by in F6Publishing: 270] [Article Influence: 26.1] [Reference Citation Analysis]
30 Qiu N, Cai LL, Xie D, Wang G, Wu W, Zhang Y, Song H, Yin H, Chen L. Synthesis, structural and in vitro studies of well-dispersed monomethoxy-poly(ethylene glycol)-honokiol conjugate micelles. Biomed Mater 2010;5:065006. [PMID: 20966535 DOI: 10.1088/1748-6041/5/6/065006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
31 Liang S, Fu A, Zhang Q, Tang M, Zhou J, Wei Y, Chen L. Honokiol inhibits HepG2 migration via down-regulation of IQGAP1 expression discovered by a quantitative pharmaceutical proteomic analysis. Proteomics 2010;10:1474-83. [PMID: 20127691 DOI: 10.1002/pmic.200900649] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
32 Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 2010;16:2571-9. [PMID: 20388852 DOI: 10.1158/1078-0432.CCR-10-0333] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
33 Domínguez F, Chávez M, Garduño-ramírez ML, Chávez-avila VM, Mata M, Cruz-sosa F. Honokiol and Magnolol Production by in vitro Micropropagated Plants of Magnolia dealbata, an Endangered Endemic Mexican Species. Natural Product Communications 2010;5:1934578X1000500. [DOI: 10.1177/1934578x1000500213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Gong C, Shi S, Wang X, Wang Y, Fu S, Dong P, Chen L, Zhao X, Wei Y, Qian Z. Novel Composite Drug Delivery System for Honokiol Delivery: Self-Assembled Poly(ethylene glycol)−Poly(ε-caprolactone)−Poly(ethylene glycol) Micelles in Thermosensitive Poly(ethylene glycol)−Poly(ε-caprolactone)−Poly(ethylene glycol) Hydrogel. J Phys Chem B 2009;113:10183-8. [DOI: 10.1021/jp902697d] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
35 Gou M, Zheng X, Men K, Zhang J, Wang B, Lv L, Wang X, Zhao Y, Luo F, Chen L, Zhao X, Wei Y, Qian Z. Self-Assembled Hydrophobic Honokiol Loaded MPEG-PCL Diblock Copolymer Micelles. Pharm Res 2009;26:2164-73. [DOI: 10.1007/s11095-009-9929-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
36 Gou M, Zheng L, Peng X, Men K, Zheng X, Zeng S, Guo G, Luo F, Zhao X, Chen L, Wei Y, Qian Z. Poly(ɛ-caprolactone)–poly(ethylene glycol)–poly(ɛ-caprolactone) (PCL–PEG–PCL) nanoparticles for honokiol delivery in vitro. International Journal of Pharmaceutics 2009;375:170-6. [DOI: 10.1016/j.ijpharm.2009.04.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
37 Wen J, Fu AF, Chen LJ, Xie XJ, Yang GL, Chen XC, Wang YS, Li J, Chen P, Tang MH. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model. Int J Cancer. 2009;124:2709-2718. [PMID: 19219913 DOI: 10.1002/ijc.24244] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
38 Oyugi DA, Luo X, Lee KS, Hill B, Izevbigie EB. Activity markers of the anti-breast carcinoma cell growth fractions of Vernonia amygdalina extracts. Exp Biol Med (Maywood) 2009;234:410-7. [PMID: 19176872 DOI: 10.3181/0811-RM-325] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
39 Cheah YH, Nordin FJ, Sarip R, Tee TT, Azimahtol HLP, Sirat HM, Rashid BAA, Abdullah NR, Ismail Z. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int 2009;9:1. [PMID: 19118501 DOI: 10.1186/1475-2867-9-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]